216 related articles for article (PubMed ID: 30778836)
1. NF1 Somatic Mutation in Dystrophic Scoliosis.
Margraf RL; VanSant-Webb C; Mao R; Viskochil DH; Carey J; Hanson H; D'Astous J; Grossmann A; Stevenson DA
J Mol Neurosci; 2019 May; 68(1):11-18. PubMed ID: 30778836
[TBL] [Abstract][Full Text] [Related]
2. Utilization of Whole-Exome Next-Generation Sequencing Variant Read Frequency for Detection of Lesion-Specific, Somatic Loss of Heterozygosity in a Neurofibromatosis Type 1 Cohort with Tibial Pseudarthrosis.
Margraf RL; VanSant-Webb C; Sant D; Carey J; Hanson H; D'Astous J; Viskochil D; Stevenson DA; Mao R
J Mol Diagn; 2017 May; 19(3):468-474. PubMed ID: 28433079
[TBL] [Abstract][Full Text] [Related]
3. Metaplastic breast cancer in a patient with neurofibromatosis type 1 and somatic loss of heterozygosity.
Suarez-Kelly LP; Akagi K; Reeser JW; Samorodnitsky E; Reeder M; Smith A; Roychowdhury S; Symer DE; Carson WE
Cold Spring Harb Mol Case Stud; 2018 Apr; 4(2):. PubMed ID: 29449315
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of somatic mutations in tibial pseudarthrosis samples in neurofibromatosis type 1.
Sant DW; Margraf RL; Stevenson DA; Grossmann AH; Viskochil DH; Hanson H; Everitt MD; Rios JJ; Elefteriou F; Hennessey T; Mao R
J Med Genet; 2015 Apr; 52(4):256-61. PubMed ID: 25612910
[TBL] [Abstract][Full Text] [Related]
5. Mitotic recombination and compound-heterozygous mutations are predominant NF1-inactivating mechanisms in children with juvenile myelomonocytic leukemia and neurofibromatosis type 1.
Steinemann D; Arning L; Praulich I; Stuhrmann M; Hasle H; Stary J; Schlegelberger B; Niemeyer CM; Flotho C
Haematologica; 2010 Feb; 95(2):320-3. PubMed ID: 20015894
[TBL] [Abstract][Full Text] [Related]
6. The primacy of NF1 loss as the driver of tumorigenesis in neurofibromatosis type 1-associated plexiform neurofibromas.
Pemov A; Li H; Patidar R; Hansen NF; Sindiri S; Hartley SW; Wei JS; Elkahloun A; Chandrasekharappa SC; ; Boland JF; Bass S; ; Mullikin JC; Khan J; Widemann BC; Wallace MR; Stewart DR
Oncogene; 2017 Jun; 36(22):3168-3177. PubMed ID: 28068329
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic endocrine tumors are a rare manifestation of the neurofibromatosis type 1 phenotype: molecular analysis of a malignant insulinoma in a NF-1 patient.
Perren A; Wiesli P; Schmid S; Montani M; Schmitt A; Schmid C; Moch H; Komminoth P
Am J Surg Pathol; 2006 Aug; 30(8):1047-51. PubMed ID: 16861979
[TBL] [Abstract][Full Text] [Related]
8. Severe Thoracic and Spinal Bone Abnormalities in neurofibromatosis type 1.
Prudhomme L; Delleci C; Trimouille A; Chateil JF; Prodhomme O; Goizet C; Van Gils J
Eur J Med Genet; 2020 Apr; 63(4):103815. PubMed ID: 31783133
[TBL] [Abstract][Full Text] [Related]
9. Germline and Somatic
Wang X; Kallionpää RA; Gonzales PR; Chitale DA; Tousignant RN; Crowley JP; Chen Z; Yoder SJ; Blakeley JO; Acosta MT; Korf BR; Messiaen LM; Tainsky MA
Cancer Prev Res (Phila); 2018 Oct; 11(10):655-664. PubMed ID: 30104415
[No Abstract] [Full Text] [Related]
10. Germline NF1 mutational spectra and loss-of-heterozygosity analyses in patients with pheochromocytoma and neurofibromatosis type 1.
Bausch B; Borozdin W; Mautner VF; Hoffmann MM; Boehm D; Robledo M; Cascon A; Harenberg T; Schiavi F; Pawlu C; Peczkowska M; Letizia C; Calvieri S; Arnaldi G; Klingenberg-Noftz RD; Reisch N; Fassina A; Brunaud L; Walter MA; Mannelli M; MacGregor G; Palazzo FF; Barontini M; Walz MK; Kremens B; Brabant G; Pfäffle R; Koschker AC; Lohoefner F; Mohaupt M; Gimm O; Jarzab B; McWhinney SR; Opocher G; Januszewicz A; Kohlhase J; Eng C; Neumann HP;
J Clin Endocrinol Metab; 2007 Jul; 92(7):2784-92. PubMed ID: 17426081
[TBL] [Abstract][Full Text] [Related]
11. Somatic NF1 mutation spectra in a family with neurofibromatosis type 1: toward a theory of genetic modifiers.
Wiest V; Eisenbarth I; Schmegner C; Krone W; Assum G
Hum Mutat; 2003 Dec; 22(6):423-7. PubMed ID: 14635100
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive NF1 screening on cultured Schwann cells from neurofibromas.
Maertens O; Brems H; Vandesompele J; De Raedt T; Heyns I; Rosenbaum T; De Schepper S; De Paepe A; Mortier G; Janssens S; Speleman F; Legius E; Messiaen L
Hum Mutat; 2006 Oct; 27(10):1030-40. PubMed ID: 16941471
[TBL] [Abstract][Full Text] [Related]
13. Somatic neurofibromatosis type 1 (NF1) inactivation characterizes NF1-associated pilocytic astrocytoma.
Gutmann DH; McLellan MD; Hussain I; Wallis JW; Fulton LL; Fulton RS; Magrini V; Demeter R; Wylie T; Kandoth C; Leonard JR; Guha A; Miller CA; Ding L; Mardis ER
Genome Res; 2013 Mar; 23(3):431-9. PubMed ID: 23222849
[TBL] [Abstract][Full Text] [Related]
14. Germline and somatic NF1 gene mutations in plexiform neurofibromas.
Upadhyaya M; Spurlock G; Monem B; Thomas N; Friedrich RE; Kluwe L; Mautner V
Hum Mutat; 2008 Aug; 29(8):E103-11. PubMed ID: 18484666
[TBL] [Abstract][Full Text] [Related]
15. A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor.
Ratner N; Miller SJ
Nat Rev Cancer; 2015 May; 15(5):290-301. PubMed ID: 25877329
[TBL] [Abstract][Full Text] [Related]
16. Toward a survey of somatic mutation of the NF1 gene in benign neurofibromas of patients with neurofibromatosis type 1.
Eisenbarth I; Beyer K; Krone W; Assum G
Am J Hum Genet; 2000 Feb; 66(2):393-401. PubMed ID: 10677298
[TBL] [Abstract][Full Text] [Related]
17. Somatic NF1 mutational spectrum in benign neurofibromas: mRNA splice defects are common among point mutations.
Serra E; Ars E; Ravella A; Sánchez A; Puig S; Rosenbaum T; Estivill X; Lázaro C
Hum Genet; 2001 May; 108(5):416-29. PubMed ID: 11409870
[TBL] [Abstract][Full Text] [Related]
18. Neurofibromatosis type 1 in two siblings due to maternal germline mosaicism.
Trevisson E; Forzan M; Salviati L; Clementi M
Clin Genet; 2014 Apr; 85(4):386-9. PubMed ID: 23621909
[TBL] [Abstract][Full Text] [Related]
19. Somatic deletion of the NF1 gene in a neurofibromatosis type 1-associated malignant melanoma demonstrated by digital PCR.
Rübben A; Bausch B; Nikkels A
Mol Cancer; 2006 Sep; 5():36. PubMed ID: 16961930
[TBL] [Abstract][Full Text] [Related]
20. Congenital pseudarthrosis of neurofibromatosis type 1: impaired osteoblast differentiation and function and altered NF1 gene expression.
Leskelä HV; Kuorilehto T; Risteli J; Koivunen J; Nissinen M; Peltonen S; Kinnunen P; Messiaen L; Lehenkari P; Peltonen J
Bone; 2009 Feb; 44(2):243-50. PubMed ID: 19061981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
